A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
Clinical trial NCT07373613 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07373613
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-02-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.